Diagnostic Accuracy of Immunohistochemistry for HER2-Positive Breast Cancer.
Siwaporn ThanasanKweekrong SukhakulSakchai ChitpakdeeNakarin KitkumthornPublished in: Asian Pacific journal of cancer prevention : APJCP (2023)
The promising outcomes suggest that a positive IHC test result (score 3+) could potentially stand alone for patients with breast cancer undergoing anti-HER2 treatment, even without DISH confirmation.